Gemma Iserte

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Systematic Review

Top Venues

Hepatology (Baltimore, Md.)

Alimentary pharmacology & therapeutics

United European gastroenterology journal

This page only lists publications with an associated author ORCID identifier.

Publications

Ismael El Hajra, Marco Sanduzzi-Zamparelli, Víctor Sapena, Sergio Muñoz-Martínez, Ezequiel Mauro, Neus Llarch, Gemma Iserte, Alejandro Forner, Jose Ríos, Jordi Bruix, Maria Reig
Outcome of patients with HCC and liver dysfunction under immunotherapy: a systematic review and meta-analysis. Hepatology (Baltimore, Md.) 77 (4) (2023)
Ismael El Hajra, Marco Sanduzzi-Zamparelli, Víctor Sapena, Sergio Muñoz-Martínez, Ezequiel Mauro, Neus Llarch, Gemma Iserte, Alejandro Forner, Jose Ríos, Jordi Bruix, Maria Reig
Outcome of patients with HCC and liver dysfunction under immunotherapy: a systematic review and meta-analysis. Hepatology (Baltimore, Md.) 77 (4) (2023)
Ismael El Hajra, Marco Sanduzzi-Zamparelli, Víctor Sapena, Sergio Muñoz-Martínez, Ezequiel Mauro, Neus Llarch, Gemma Iserte, Alejandro Forner, Jose Ríos, Jordi Bruix, Maria Reig
Outcome of patients with HCC and liver dysfunction under immunotherapy: a systematic review and meta-analysis. Hepatology (Baltimore, Md.) 77 (4) (2023)
Álvaro Díaz-González, Víctor Sapena, Loreto Boix, Ferràn Torres, Marco Sanduzzi-Zamparelli, Leonardo Gomes da Fonseca, Neus Llarch, Gemma Iserte, Cassia Guedes, Sergio Muñoz-Martínez, Anna Darnell, Ernest Belmonte, Jordi Rimola, Alejandro Forner, Carmen Ayuso, Jordi Bruix, Maria Reig
Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs. United European gastroenterology journal 9 (6) (2021)
Álvaro Díaz-González, Marco Sanduzzi-Zamparelli, Víctor Sapena, Ferràn Torres, Neus Llarch, Gemma Iserte, Alejandro Forner, Leonardo Gomes da Fonseca, Jose Ríos, Jordi Bruix, Maria Reig
Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib. Alimentary pharmacology & therapeutics 49 (5) (2019)